13F-HR filed by a16z Capital Management, L.L.C.
a16z Capital Management, L.L.C. filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 19 holding rows worth $14,214,935,834.
- Accession
- 0001540358-26-000010
- Filer
- CIK 1540358
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 19 entries on the cover page, a total value of $14,214,935,834 stated on the cover page (in dollars after the unit check, H1), rows summing to $14,214,935,834 with VALUE read as dollars as filed, 13F file number 028-23922. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPACE EXPLORATION TECHN CORP CLASS A COM STK | 84615Q103 | Stock | 74,855,020 | $12,789,728,717 | dollars as filed | |
| NAVAN INC CL A | 639193101 | Stock | 28,218,676 | $645,361,120 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 921,099 | $172,503,421 | dollars as filed | |
| META PLATFORMS INC CL A | 30303M102 | COM | 212,531 | $119,716,587 | dollars as filed | |
| FIGMA INC CL A | 316841105 | COM | 5,983,308 | $108,238,042 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 3,233,170 | $79,244,997 | dollars as filed | |
| BLOCK INC CL A | 852234103 | Stock | 1,016,697 | $77,268,972 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 2,862,500 | $52,441,000 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 1,702,225 | $50,794,394 | dollars as filed | |
| DAMORA THERAPEUTICS INC | 36322Q206 | COMMON STOCK | 1,236,157 | $32,152,444 | dollars as filed | |
| OMADA HEALTH INC | 68170A108 | COM | 1,153,639 | $25,322,376 | dollars as filed | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 9,063,054 | $16,947,911 | dollars as filed | |
| ROBLOX CORP CL A | 771049103 | Stock | 274,570 | $14,931,117 | dollars as filed | |
| AKTIS ONCOLOGY INC | 01021M104 | COMMON STOCK | 415,000 | $13,375,450 | dollars as filed | |
| CAMP4 THERAPEUTICS CORP | 13463J101 | COM | 2,125,339 | $9,287,731 | dollars as filed | |
| BITGO HOLDINGS INC-CL A | 091947101 | COM SHS CL A | 666,356 | $3,451,724 | dollars as filed | |
| KAILERA THERAPEUTICS INC | 482931102 | COMMON STOCK | 140,000 | $3,084,200 | dollars as filed | |
| GINKGO BIOWORKS HOLDINGS INC | 37611X209 | COMMON STOCK | 108,568 | $1,075,909 | dollars as filed | |
| IP STRATEGY HOLDINGS INC | 42727R302 | COM | 4,137 | $9,722 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001540358-26-000010 | this filing | 2026-08-14 | acceptance time not in the bulk data set |